Mendelian randomization of blood lipids for coronary heart disease. - Wikidata - thesis-toulmin - TriplyDB

Mendelian randomization of blood lipids for coronary heart disease.

Mendelian randomization of blood lipids for coronary heart disease.

http://www.wikidata.org/entity/Q30407506

about

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?Cholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic Review Polygenic Epidemiology HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis Mendelian randomization: genetic anchors for causal inference in epidemiological studies Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.Genetic analysis of a mouse cross implicates an anti-inflammatory gene in control of atherosclerosis susceptibility.Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.High-density lipoprotein and endothelial function in patients with myocardial infarction: Pieces in a puzzle.Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity.Skin pigmentation, sun exposure and vitamin D levels in children of the Avon Longitudinal Study of Parents and Children Genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the rat Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis.Exploring causal associations of alcohol with cardiovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients.The impact of common polymorphisms in CETP and ABCA1 genes with the risk of coronary artery disease in Saudi Arabians.Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II.Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase-Independent Effects.Blood lipids and prostate cancer: a Mendelian randomization analysis.Genetic susceptibility to dyslipidemia and incidence of cardiovascular disease depending on a diet quality index in the Malmö Diet and Cancer cohort.Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner.The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.Ten-year alcohol consumption typologies and trajectories of C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist over the following 12 years: a prospective cohort study.Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?Dysfunctional HDL and atherosclerotic cardiovascular disease.The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis.Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention.

P2860

Q24187425-2ED34585-979F-4E72-A60D-1DF0689F60C8 Q24289296-37F0B55C-F8FF-4A8E-A34E-9F274FD0A3E1 Q26746279-C152710A-440E-4847-B451-2D530CB2E88D Q26748320-B9672AFB-D942-408E-BA9D-52A240C22EAD Q26750522-4489E402-2ABE-4EB7-8AD3-51C1575543DC Q26782972-E2AD5342-C2A4-4860-9E49-C72462A01DE4 Q27002487-56C511F6-571D-4801-A13D-FE8EAD494E69 Q28070061-A460022F-C9AA-46AA-BE24-00E6C10C269E Q30234302-C3D5ED85-05C5-476C-83D1-E59CC957F2C7 Q30252873-0ED2795A-03F5-4006-A5B0-3FE74ECB0AF1 Q30274938-92E80952-7290-480D-B9B2-303F1C99FE63 Q30489063-612A1D08-BC66-4A51-A26D-2D39D6C875A1 Q31053398-767342C6-B652-44EF-A7C9-46D66194783B Q31129488-2F4A0A64-EAA1-46C8-BFD0-52F67113B2E3 Q33359597-341A0C32-3CE8-4445-83D6-140D574E1A6E Q33672059-B1C5E3A4-AC02-4060-9996-A0B01BE653AC Q33792547-16B9B0D5-49DD-4D41-B04B-34E71E6A16E0 Q34308879-A09E4823-E199-4C43-B460-A8646FD9D74D Q34554918-C302051C-2CE7-422B-95AB-5486398194FE Q35319656-21CC95D9-FDAB-42EA-9257-AC8D2659FB9D Q35712593-9BEE8F06-28F0-4A53-B55D-6579918D4DD2 Q36056254-C13B11F5-BDA6-4FD2-9B71-A5A2B5A17E45 Q36355894-95FB5022-5F01-4392-BBA1-4B1245ABAB4E Q36423189-2D25864F-4A94-4FD0-BEFC-222DD9AA5102 Q36646137-798F14FB-5AA5-49BC-8547-5A94B4DD717A Q36836880-40D9E14D-2EE0-4BB9-A1EA-B8CB7EBB670F Q37036336-0A451949-499F-4A42-BFC7-ADAC43D6CC18 Q37045556-BA33DDF7-E79F-421B-A683-5A8132069326 Q37142066-A1826438-ECF6-4F06-AD13-F13E9CAB6A56 Q37195954-68E77A8A-6959-4523-A055-1639DF0E410C Q37227150-193022EB-6EAE-463C-A42A-4C61FBDFCFFF Q37251406-6124D482-3F42-4919-A1F3-D76F303205AF Q37401173-7A8D195B-5BB7-41BF-BDF0-B099A83C3A5A Q37520958-4F81E1E8-ACC4-4CEC-8F11-3DCEAF2A4476 Q37648324-2034925E-F361-4E26-A8DC-53201696EF29 Q38420505-EF0D6106-2F78-4652-9819-9D4BFE35B751 Q38511045-21183488-3B94-4B5E-B75B-73097155D589 Q38577283-6DE85A44-F6F7-463D-8CEC-10DA7D1CF1A5 Q38578940-2378BE9B-6D03-47B2-B19C-E5AB75755A37 Q38610278-12B5C3E1-CA44-4CF2-B224-FB9256500022

P2860

Mendelian randomization of blood lipids for coronary heart disease.

http://www.wikidata.org/entity/Q30407506

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mendelian randomization of blood lipids for coronary heart disease.

@ast

Mendelian randomization of blood lipids for coronary heart disease.

@en

Mendelian randomization of blood lipids for coronary heart disease.

@en-gb

type

label

Mendelian randomization of blood lipids for coronary heart disease.

@ast

Mendelian randomization of blood lipids for coronary heart disease.

@en

Mendelian randomization of blood lipids for coronary heart disease.

@en-gb

prefLabel

Mendelian randomization of blood lipids for coronary heart disease.

@ast

Mendelian randomization of blood lipids for coronary heart disease.

@en

Mendelian randomization of blood lipids for coronary heart disease.

@en-gb

P1433

Q30407506-356F2B90-404C-44F5-AF30-C751F33E2915

P1476

Q30407506-6314F789-3B2E-40C1-8333-8354BEC17EFA

P2093

Q30407506-01CF3E37-D99F-43F8-A4C3-7C75A2502955

Q30407506-191C9EFE-D86E-4C38-82B0-C1BF0293181B

Q30407506-208BB15D-9DCD-4EA5-B599-2FEE34DD33BB

Q30407506-2DA04E68-3FF1-4F3F-8170-31B328B26D1B

Q30407506-3DFC88CE-7B3D-43DB-9B91-59CC077A5B88

Q30407506-4199780A-247B-43BB-8926-9213C6332402

Q30407506-479DCCA7-F83A-49A6-8922-8FF7221A7DBD

Q30407506-4BD4C1F2-E8B0-4E09-B0C4-B5F6C2899AAD

Q30407506-4E685351-C5E5-4E07-B78C-6FDAA7D9FEA5

Q30407506-5672DA28-2482-4E03-8B76-9B167272CA4F

P2860

Q30407506-090ED06B-8CD8-4CC6-B6EB-7054D505B3C8

Q30407506-0B00F404-AD5A-46A2-9225-2AA70712F017

Q30407506-0D70EDD3-48CA-486A-A520-636A4B02E190

Q30407506-1155BFD9-AB3A-4830-97B3-8567B58B8228

Q30407506-11CE10D7-8AFE-42AA-AABD-BC55831E871D

Q30407506-1B4BA6FF-067C-4BDF-890C-643B0105B9D6

Q30407506-2083B4F9-3191-4C3A-A448-A5D4B823EC88

Q30407506-34F7CE8A-95D5-479C-936B-D66F3B02991A

Q30407506-3C5FD7BF-C6D5-4F72-9551-35B442E02527

Q30407506-40C6ADE8-2031-49C1-97C6-231F7A4A756C

P304

Q30407506-499BEEF5-E7F8-46AE-A053-EF06B85DA6D1

P31

Q30407506-19782210-BE0C-40B3-A94E-A02A816A2141

Q30407506-c86b94e3-e110-4670-8794-8ef74f1540aa

P356

Q30407506-20C5287B-3A65-4CFF-96CA-CD8892FC13DC

P433

Q30407506-EA2F9C7F-F354-4429-940E-0E5E97EFD262

P478

Q30407506-03AECF67-BC61-45E4-8F08-144DC6656BBA

P50

Q30407506-0E3CDF39-3C0D-4D3C-8055-99832DEB8869

Q30407506-109396E8-DA04-4D7F-A29D-21EDAC82F655

Q30407506-16C87E4A-7D87-457B-97EE-AC5A401D2487

Q30407506-18A606DA-CFC6-47DA-AD1E-20052E65CD1C

Q30407506-23CD273F-BDD4-49CA-A92D-9B215CB6BCAB

Q30407506-2971A6C6-F860-46B0-ACCA-1F505A697F56

Q30407506-30CEEE6F-118B-4246-8233-1A96C32298AB

Q30407506-3B63C723-F8FF-4BDF-986B-37F02F6C0BCE

Q30407506-46C21E6D-3DDD-4F51-91F8-A5A34A062147

Q30407506-47317E25-4E4F-40AE-9958-2C94E3DD0E31

P577

Q30407506-C0CD3B0E-C149-428D-8EA2-D012975C4CD4

P5875

Q30407506-6C30AF5D-9EE6-42CA-A2EC-42AE47A60022

P698

Q30407506-03999BA1-F1F5-4528-9E07-010BB026BF8C

P932

Q30407506-3C4D859F-3613-49E9-895C-AAF1E50D4D76

P356

P1433

European Heart Journal

P1476

Mendelian randomization of blood lipids for coronary heart disease.

@en

P2093

Alex P Reiner

http://www.w3.org/2001/XMLSchema#string

Anthony J Balmforth

http://www.w3.org/2001/XMLSchema#string

Berta Almoguera

http://www.w3.org/2001/XMLSchema#string

Brendan J Keating

http://www.w3.org/2001/XMLSchema#string

Caroline E Dale

http://www.w3.org/2001/XMLSchema#string

Chris Finan

http://www.w3.org/2001/XMLSchema#string

Clara C Elbers

http://www.w3.org/2001/XMLSchema#string

Claudia Giambartolomei

http://www.w3.org/2001/XMLSchema#string

Erik P A van Iperen

http://www.w3.org/2001/XMLSchema#string

Fotios Drenos

http://www.w3.org/2001/XMLSchema#string

P2860

Biological, clinical and population relevance of 95 loci for blood lipids

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Effects of torcetrapib in patients at high risk for coronary events

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.

Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

P304

539-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHT571

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Koenig

Sandosh Padmanabhan

Michael Y. Tsai

Richard W. Morris

Philippa Talmud

P577

2014-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259931707

http://www.w3.org/2001/XMLSchema#string

P698

24474739

http://www.w3.org/2001/XMLSchema#string

P932

4344957

http://www.w3.org/2001/XMLSchema#string